SCHEMBL6622844

SCHEMBL6622844

CCN(CC)CCOc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2c(Cl)cc(Cl)cc2Cl)C3)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 3/20 0.86
MAPK14 Q16539 2/20 0.86
RIPK2 O43353 8/20 0.54
NOD2 Q9HC29 8/20 0.54
WEE1 P30291 7/20 0.54
ACVR1 Q04771 7/20 0.53
SRC P12931 3/20 0.53
FGFR1 P11362 2/20 0.53
FGFR4 P22455 2/20 0.53
CHEK1 O14757 1/20 0.53
JAK2 O60674 1/20 0.53
PRKD3 O94806 1/20 0.53
MAP4K4 O95819 1/20 0.53
PAK4 O96013 1/20 0.53
ABL1 P00519 1/20 0.53
EGFR P00533 1/20 0.53
NTRK1 P04629 1/20 0.53
FYN P06241 1/20 0.53
CSF1R P07333 1/20 0.53
RET P07949 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6619817 0.93 LCK (1.00) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL6622471 0.91 LCK (0.76) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL6625412 0.89 LCK (0.76) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL6619659 0.88 LCK (0.91) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL6620988 0.87 LCK (0.84) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL6622434 0.87 LCK (0.83) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL3574541 0.87 LCK (0.75) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL6621364 0.86 LCK (0.82) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL6617765 0.85 LCK (0.78) LCKMAPK14RIPK2NOD2WEE1
SCHEMBL6622119 0.84 LCK (0.74) LCKMAPK14RIPK2NOD2WEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123295-B1 BICYCLIC NITROGEN HETEROCYCLES HOFFMANN LA ROCHE (CH) 2004-09-29 EP disclosed
US-6150373-A AMINO-SUBSTITUTED DIHYDROPYRIMIDO(4,5-D)PYRIMIDINONE DERIVATIVES; INHIBITORS OF THE T-CELL TYROSINE KINASE P56LCK; IMMUNOSUPPRESSANTS; ANTIINFLAMMATORY/-CARCINOGENIC AGENTS; BRONCHOPULMONARY, DERMATOLOGICAL AND CARDIOVASCULAR DISORDERS HOFFMANN-LA ROCHE INC. (US) 2000-11-21 US disclosed